The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, X.
Right arrow Articles by Konig, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, X.
Right arrow Articles by Konig, R.

The Journal of Immunology, Vol 157, Issue 1 87-100, Copyright © 1996 by American Association of Immunologists


ARTICLES

Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo

X Shen, B Hu, P McPhie, X Wu, A Fox, RN Germain and R Konig
Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston 77555, USA.

Immune responses mediated by CD4+ T cells depend on Ag-specific alpha beta TCRs that recognize the specific antigenic peptide presented by MHC class II molecules. Interactions between CD4 coreceptors and monomorphic regions of MHC class II molecules contribute to these responses. To examine whether immune reactions could be modulated by specifically interfering with CD4-MHC class II interactions, we have used, in various in vitro and in vivo assays, peptides that correspond to a region of MHC class II molecules previously shown to control interaction with CD4. Depending on the chemical nature and concentration of these peptides, they modulated Ag-specific responses of CD4+ T cells. At high concentrations, these peptides inhibited T cell responses in vitro. However, under conditions that can cause Ag- induced unresponsiveness, the peptides enhanced T cell responses. Also, primary in vivo immune responses to systemically administered soluble protein Ag, keyhole limpet hemocyanin, were enhanced when mice were treated with peptides corresponding to the CD4-interacting region of MHC class II molecules but not when treated with control peptides. Lymphokine profiles suggested that the peptides may favor the differentiation of Th1 cells, because lymphocytes from peptide-treated mice secreted more IL-2 and IFN-gamma than lymphocytes from nontreated or control-peptide-treated mice upon restimulation with Ag in vitro. These results demonstrate that MHC class II-derived peptides can directly interfere with interactions with CD4 and modulate T cell responses in vitro and in vivo.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
J. E. Comer, A. K. Chopra, J. W. Peterson, and R. Konig
Direct Inhibition of T-Lymphocyte Activation by Anthrax Toxins In Vivo
Infect. Immun., December 1, 2005; 73(12): 8275 - 8281.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. L. Denning, H. Qi, R. Konig, K. G. Scott, M. Naganuma, and P. B. Ernst
CD4+ Th Cells Resembling Regulatory T Cells That Inhibit Chronic Colitis Differentiate in the Absence of Interactions Between CD4 and Class II MHC
J. Immunol., September 1, 2003; 171(5): 2279 - 2286.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Ito, H. Takaishi, Y. Jin, F. Song, T. L. Denning, and P. B. Ernst
Staphylococcal Enterotoxin B Stimulates Expansion of Autoreactive T Cells That Induce Apoptosis in Intestinal Epithelial Cells: Regulation of Autoreactive Responses by IL-10
J. Immunol., March 15, 2000; 164(6): 2994 - 3001.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. MURPHY and A. M. KRENSKY
HLA-Derived Peptides as Novel Immunomodulatory Therapeutics
J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1346 - 1355.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
R. Maroto, X. Shen, and R. Konig
Requirement for Efficient Interactions Between CD4 and MHC Class II Molecules for Survival of Resting CD4+ T Lymphocytes In Vivo and for Activation-Induced Cell Death
J. Immunol., May 15, 1999; 162(10): 5973 - 5980.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Gilfillan, X. Shen, and R. Konig3
Selection and Function of CD4+ T Lymphocytes in Transgenic Mice Expressing Mutant MHC Class II Molecules Deficient in Their Interaction with CD4
J. Immunol., December 15, 1998; 161(12): 6629 - 6637.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Leitenberg, Y. Boutin, S. Constant, and K. Bottomly
CD4 Regulation of TCR Signaling and T Cell Differentiation Following Stimulation with Peptides of Different Affinities for the TCR
J. Immunol., August 1, 1998; 161(3): 1194 - 1203.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. R. Brown, N. H. Moskowitz, N. Killeen, and S. L. Reiner
A Role for CD4 in Peripheral T Cell Differentiation
J. Exp. Med., July 7, 1997; 186(1): 101 - 107.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.